Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Vioxx studies question timing of heart attack risk.
- In lawsuits against Merck & Co. for injuries caused by its now-withdrawn painkiller Vioxx, the company has maintained that the drug causes increased risk of heart attack and stroke only after the patient takes it for 18 months. Two recent studies cast doubt on that assertion. ...
- Research articles 2006-07-01
- Industry sponsorship of drug studies raises concerns of bias
- WASHINGTON AFP — Seemingly independent drug laboratory trials in the United States are increasingly financed by the same companies that produce the drugs, which doctors and consumer advocates say can skew the test results. The problem was highlighted in a recent scandal over Merck and Co's pain relief drug...
- Research articles 2006-06-03
- Heart problems seen in first weeks of Vioxx use: Canadian study
- MONTREAL AFP — A new study that tracked 125,000 Canadian users of the once-popular painkiller Vioxx found an increased risk of heart attack or stroke in the first two weeks of treatment, researchers said. "A quarter of individuals in our study who suffered an acute myocardial infarction did so...
- Research articles 2006-05-03
- US jury finds Merck not liable for death of Vioxx user
- NEW YORK, United States AFP — A US federal jury has decided US pharmaceutical giant Merck and Co. is not liable for the 2001 death of a Florida man who had taken the company's Vioxx pain medication. The jury's finding was the first in a federal court, and the...
- Research articles 2006-02-17
- No verdict yet in Vioxx trial
- HOUSTON, United States AFP — Jurors at a federal court were unable to reach a verdict the first federal case brought against drug maker Merck for problems with its popular pain medication Vioxx. Judge Eldon Fallon, who is presiding the case, sent the five men and four women of...
- Research articles 2005-12-10
- Kenya says banned Vioxx generics still on market, pursues violators
- NAIROBI AFP — Health officials in Kenya said they believed generic versions of the banned painkiller Vioxx are still being sold here and vowed to crack down on pharmacists and others still peddling the drug. "We have reports that some pharmacies are still selling the drug although it has...
- Research articles 2005-08-30
- Merck plans legal fight after jury awards widow 253 million
- WHITEHOUSE STATION, New Jersey, AFP — US pharmaceutical giant Merck and Co. said it will continue to fight to prove its innocence after a Texas jury found it guilty in a wrongful death case brought by the widow of a man who died after using its blockbuster arthritis painkiller Vioxx....
- Research articles 2005-08-20
- Troubles loom for Merck after jury awards widow 253 million
- ANGLETON, United States AFP — New legal troubles loomed for US pharmaceutical giant Merck and Co. after a Texas jury found it guilty in a wrongful death case brought by the widow of a man who died after using its blockbuster arthritis painkiller Vioxx. The jury here awarded damages...
- Research articles 2005-08-20
- US jury finds Merck guilty in Vioxx trial, awards huge damages
- ANGLETON, United States AFP — US pharmaceutical giant Merck and Co. was found guilty in a high-profile wrongful death case brought by the widow of a man who died after using its blockbuster arthritis painkiller Vioxx. A jury here awarded damages totalling more than 253 million dollars to Carol...
- Research articles 2005-08-19
- Troubles loom for Merck after jury awards widow 253 million dollars
- ANGLETON, United States AFP — New legal troubles are looming for US pharmaceutical giant Merck and Co. following a Texas jury finding it guilty in a wrongful death case brought by the widow of a man who died after using its blockbuster arthritis painkiller Vioxx. The jury here awarded...
- Research articles 2005-08-20
- 50 French patients join US lawsuit against Merck over Vioxx
- PARIS AFP — Some 50 French people claiming they suffered cardiac problems after using the arthiritis painkiller Vioxx are joining a US lawsuit against the drug's maker, Merck, an association representing them said. An agreement with a US law firm meant their cases would be included in a class...
- Research articles 2005-07-04
- Some drug prices go up after rivals leave market
- Prices of some prescription drugs rose sharply after rivals left the market recently, but drugmakers say there's no connection. *Wholesale prices for leading multiple sclerosis drugs Avonex and Copaxone jumped in May by 8% and 9.4%, respectively, their makers confirmed Friday. In February, sales of MS drug Tysabri were...
- Research articles 2005-06-06
- Merck Scores Vioxx Win in State High Court
- The state Supreme Court handed Merck & Co. a victory last week when it reversed a lower court ruline that had granted nationwide class-action status to insurance companies and health maintenance organizations seeking reimbursement for Vioxx expenditures.
- Research articles 2007-09-10
- FDA panel votes to keep pain killer Celebrex on market
- WASHINGTON AFP — A special panel of the US Food and Drug Administration voted to allow Pfizer's pain killer Celebrex to remain on the market, despite a finding that it can cause heart problems in some patients. The decision came from a joint meeting of the agency's Arthritis Advisory...
- Research articles 2005-02-18
- Interview With Jeff Gannon
- ANDERSON COOPER, HOST: Good evening from New York. I'm Anderson Cooper. He was a White House reporter, now he's the center of a political firestorm. 360 starts now. New questions about the man...
- Research articles 2005-02-18
- Research confirms health risks of Vioxx, Celebrex and Bextra
- WASHINGTON AFP — New research by Wellpoint Inc., the leading US private health insurance group, has confirmed a higher risk of heart attacks with the use of painkillers such as Vioxx, Bextra and Celebrex. In a letter to the Food and Drug Administration FDA, Wellpoint director Samuel Nussbaum said...
- Research articles 2005-02-16
- Vioxx may have caused up to 140,000 US cases of heart disease: study
- PARIS AFP — The controversial painkiller Vioxx may have caused as many as 140,000 cases of serious coronary heart disease in the United States before it was pulled from shelves last September, according to a much-awaited study published. People taking Vioxx had a 34 percent higher chance of developing...
- Research articles 2005-01-24
- US cardiologists calls for testing FDA-approved drugs
- WASHINGTON AFP — The health risks found in pain-relieving drugs known as COX-2 inhibitors, such as Vioxx, underscore the need for health authorities to test drugs already on the market, a top US cardiologist warned. In an article posted Tuesday on the Journal of the American Medical Association's website,...
- Research articles 2004-12-29
- Richmond Times-Dispatch, Va., Consumer Watch column.
- By Iris Taylor, Richmond Times-Dispatch, Va. Knight Ridder/Tribune Business News Nov. 27--WEB SITES HAVE GOOD INFORMATION ON DRUG SAFETY: If there's a lesson to be learned from Vioxx, Merck & Co.'s recalled painkiller linked to heart attacks and strokes, it is that...
- Research articles 2004-11-27
- Merck shares slide on civil, criminal probes into Vioxx
- WASHINGTON AFP — Drugs giant Merck and Co.'s shares slumped after the firm revealed civil and criminal investigations into the sale of its pain drug Vioxx. In the first half hour of trade, Merck shares dropped 55 cents, or 2.1 percent, to 26.02 dollars, completing a 42.3 percent plunge...
- Research articles 2004-11-09
- << Previous
- page 1 of 4
- Next >>
Content Types
Refining Tags
- Merck & Co. Inc. (56 results)
- Agence France-Presse (18 results)
- FDA (14 results)
- Government (12 results)
- patient (6 results)
- HEALTHCARE (6 results)
- SOFTWARE (6 results)
- Benefits (5 results)
- Pfizer Inc. (4 results)
- medication (4 results)
- SALES (4 results)
- insurance company (4 results)
- Litigation (3 results)
- advertisement (3 results)
- class action (3 results)
- Marketing (3 results)
- withdrawal (3 results)
- health care (3 results)
